ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

SAIC-Frederick Makes Awards To Proteomics Research Teams.

January 14, 2005

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

May 18, 2007

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

Stephen Gruber Named Director at USC Norris; TGen and Cedars-Sinai to Coordinate Phase I Trials.

October 21, 2011

Regulatory Policy: Bush To Seek Legislation For Pediatric Drug Tests.

January 3, 2003

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986